Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry

被引:28
作者
Thevis, Mario [1 ]
Kohler, Maxie [1 ]
Thomas, Andreas [1 ]
Schloerer, Nils [2 ]
Schaenzer, Wilhelm [1 ]
机构
[1] German Sport Univ Cologne, Inst Biochem, Ctr Prevent Doping Res, D-50933 Cologne, Germany
[2] Univ Cologne, Inst Organ Chem, D-50939 Cologne, Germany
关键词
D O I
10.1002/rcm.3637
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Selective androgen receptor modulators represent an emerging class of therapeutics to counteract various diseases such as osteoporosis and muscle wasting. Numerous drug candidates have been developed and investigated including a group that comprises a tricyclic tetra hydroquinoline nucleus such as 2-methyl-2- (8-nitro-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]chinolin-4-yl)propan-1-ol. Due to their novelty and medicinal purpose, these compounds also possess great potential for misuse in sports, and studies on the mass spectrometric behavior of three synthesized model substances and drug candidates were conducted to provide information on typical dissociation pathways following electrospray ionization and collision-induced dissociation. Product ion mass spectra derived from protonated molecules were studied using high resolution/high accuracy orbitrap mass spectrometry, and characteristic fragmentation routes and product ions were elucidated. Major and general findings include the elimination of a hydroxyl radical from [M+H](+), the elimination of the 2-substituted side chain, and the gas-phase rearrangement of the investigated tricyclic tetrahydroquinolines to 6-nitroquinoline yielding a common product ion at m/z 1.75. Knowledge of these dissociation pathways supports the identification of related substances as well as metabolic products, which is of utmost importance to drug testing laboratories. The compounds were implemented into existing screening procedures, and detection limits (0.2-0.6ng/mL), recoveries (92-197%), and intraday and interclay precision (<22%) were evaluated. Copyright (D\C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:2471 / 2478
页数:8
相关论文
共 36 条
[1]   Selective androgen receptor modulators in drug discovery: Medicinal chemistry and therapeutic potential [J].
Cadilla, Rodolfo ;
Turnbull, Philip .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (03) :245-270
[2]   Discovery of nonsteroidal androgens [J].
Dalton, JT ;
Mukherjee, A ;
Zhu, ZX ;
Kirkovsky, L ;
Miller, DD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 244 (01) :1-4
[3]   Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid [J].
Dams, R ;
Huestis, MA ;
Lambert, WE ;
Murphy, CM .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2003, 14 (11) :1290-1294
[4]   Theoretical model calculations of the absolute proton affinities of benzonitrile, nitroso- and nitrobenzene [J].
Eckert-Maksic, M ;
Hodoscek, M ;
Kovacek, D ;
Maksic, ZB ;
Primorac, M .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 1997, 417 (1-2) :131-143
[5]  
FRANK HP, 1964, MONATSH CHEM, V95, P410
[6]   Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs) [J].
Gao, Wenqing ;
Dalton, James T. .
DRUG DISCOVERY TODAY, 2007, 12 (5-6) :241-248
[7]   Characterization of the in vitro metabolism of selective androgen receptor modulator using human, rat, and dog liver enzyme preparations [J].
Gao, WQ ;
Wu, ZR ;
Bohl, CE ;
Yang, J ;
Miller, DD ;
Dalton, JT .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (02) :243-253
[8]   Feasibility of different mass spectrometric techniques and programs for automated metabolite profiling of tramadol in human urine [J].
Hakala, Kati S. ;
Kostiainen, Risto ;
Ketola, Raimo A. .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2006, 20 (14) :2081-2090
[9]   Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators [J].
Hamann, Lawrence G. ;
Manfredi, Mark C. ;
Sun, Chongqing ;
Krystek, Stanley R., Jr. ;
Huang, Yanting ;
Bi, Yingzhi ;
Augeri, David J. ;
Wang, Tammy ;
Zou, Yan ;
Betebenner, David. A. ;
Fura, Aberra ;
Seethala, Ramakrishna ;
Golla, Rajasree ;
Kuhns, Joyce E. ;
Lupisella, John A. ;
Darienzo, Celia J. ;
Custer, Laura L. ;
Price, Jennifer L. ;
Johnson, James M. ;
Biller, Scott A. ;
Zahler, Robert ;
Ostrowski, Jacek .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) :1860-1864
[10]   Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6(trifluoromethyl)-8-pyridono[5,6-g]-quinoline (LG121071) [J].
Hamann, LG ;
Mani, NS ;
Davis, RL ;
Wang, XN ;
Marschke, KB ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :210-212